** Shares of Clarity Pharmaceuticals CU6.AX down 15% to A$3.025, top losers on the S&P/ASX 200 .AXJO benchmark index
** Stock falls as much as 26% to A$2.644 earlier in the day, their lowest level since April 30, 2024
** Radiopharmaceutical co said on Friday HY loss attributable widened to A$23 mln ($14.30 mln) from A$17 mln a year earlier
** Five mln shares change hands, 3.4 times the 30-day average of 1.5 mln
** Stock down 27.6% YTD, including current session's moves
($1 = 1.6080 Australian dollars)
(Reporting by Manasi Dasa in Bengaluru)
((Manasi.DasaSundeep@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。